Cargando…
MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression
Colorectal cancer (CRC) is one of the leading cancers worldwide, accounting for high morbidity and mortality. The mechanisms governing tumor growth and metastasis in CRC require detailed investigation. The results of the present study indicated that the transcription factor (TF) myocyte enhancer fac...
Autores principales: | Xiao, Qing, Gan, Yaqi, Li, Yimin, Fan, Lili, Liu, Jiaqi, Lu, Pengyan, Liu, Jiaxin, Chen, Aoao, Shu, Guang, Yin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116210/ https://www.ncbi.nlm.nih.gov/pubmed/33863999 http://dx.doi.org/10.1038/s41388-021-01774-w |
Ejemplares similares
-
Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer
por: Li, Yimin, et al.
Publicado: (2022) -
EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer
por: Li, Yimin, et al.
Publicado: (2020) -
Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer
por: Liu, Jiaxin, et al.
Publicado: (2022) -
Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
por: Liu, Jiaxin, et al.
Publicado: (2021) -
CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer
por: Gan, Yaqi, et al.
Publicado: (2018)